XML 17 R6.htm IDEA: XBRL DOCUMENT v3.22.2
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (UNAUDITED) - USD ($)
$ in Millions
Total
Common Stock
Accumulated Other Comprehensive Income (Loss)
Additional Paid-in Capital
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2020   136,017,964      
Beginning balance at Dec. 31, 2020 $ 1,537 $ 1 $ (66) $ 2,629 $ (1,027)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) attributable to Covetrus (47)       (47)
Redeemable non-controlling interest redemption value adjustment (2)     (2)  
Issuance of shares in connection with share-based compensation plans, net of shares withheld for taxes (in shares)   1,341,740      
Issuance of shares in connection with share-based compensation plans, net of shares withheld for taxes (11)     (11)  
Share-based compensation 25     25  
Other comprehensive income (loss) 0   0    
Ending balance (in shares) at Jun. 30, 2021   137,359,704      
Ending balance at Jun. 30, 2021 1,502 $ 1 (66) 2,641 (1,074)
Beginning balance (in shares) at Mar. 31, 2021   136,342,036      
Beginning balance at Mar. 31, 2021 1,520 $ 1 (75) 2,637 (1,043)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) attributable to Covetrus (31)       (31)
Redeemable non-controlling interest redemption value adjustment (2)     (2)  
Issuance of shares in connection with share-based compensation plans, net of shares withheld for taxes (in shares)   1,017,668      
Issuance of shares in connection with share-based compensation plans, net of shares withheld for taxes (8)     (8)  
Share-based compensation 14     14  
Other comprehensive income (loss) 9   9    
Ending balance (in shares) at Jun. 30, 2021   137,359,704      
Ending balance at Jun. 30, 2021 $ 1,502 $ 1 (66) 2,641 (1,074)
Beginning balance (in shares) at Dec. 31, 2021 138,011,969 138,011,969      
Beginning balance at Dec. 31, 2021 $ 1,511 $ 1 (79) 2,670 (1,081)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) attributable to Covetrus (6)       (6)
Issuance of shares in connection with the Acquisition (in shares)   573,365      
Issuance of shares in connection with acquisitions 10     10  
Issuance of shares in connection with share-based compensation plans, net of shares withheld for taxes (in shares)   1,253,930      
Issuance of shares in connection with share-based compensation plans, net of shares withheld for taxes (2)     (2)  
Share-based compensation 23     23  
Other comprehensive income (loss) $ (31)   (31)    
Ending balance (in shares) at Jun. 30, 2022 139,839,264 139,839,264      
Ending balance at Jun. 30, 2022 $ 1,505 $ 1 (110) 2,701 (1,087)
Beginning balance (in shares) at Mar. 31, 2022   139,143,360      
Beginning balance at Mar. 31, 2022 1,528 $ 1 (81) 2,691 (1,083)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) attributable to Covetrus (4)       (4)
Issuance of shares in connection with share-based compensation plans, net of shares withheld for taxes (in shares)   695,904      
Issuance of shares in connection with share-based compensation plans, net of shares withheld for taxes 0        
Share-based compensation 10     10  
Other comprehensive income (loss) $ (29)   (29)    
Ending balance (in shares) at Jun. 30, 2022 139,839,264 139,839,264      
Ending balance at Jun. 30, 2022 $ 1,505 $ 1 $ (110) $ 2,701 $ (1,087)